Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




The STAR Trial: Evidence for Raloxifene as a Breast Cancer Risk Reduction Agent for Postmenopausal W
Link ID 613
Title The STAR Trial: Evidence for Raloxifene as a Breast Cancer Risk Reduction Agent for Postmenopausal W
Url http://www.medscape.com/viewarticle/564214?src=rss
Description Postmenopausal women at increased risk for breast cancer may now have a new option for reducing risk that differs from standard approaches in important ways.
Journal of the National Comprehensive Cancer Network
Category Articles > Emergency Medicine
Keywords
Date Nov 9, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Emergency Medicine
1. Denosumab Useful in Treating Aromatase-Inhibitor-Induced Bone Loss
  With a different mechanism of action than current options, denosumab is showing promise for breast cancer patients with aromatase-inhibitor-induced bone loss. Medscape Medical News
Category:   Articles > Emergency Medicine


2. Challenging Cases in Acute Blood Pressure Management: Putting the Guidelines Into Practice
  Review treatment strategies for acute blood pressure management of acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage.
Category:   Articles > Emergency Medicine


3. Nonadherence to Antiepileptic Drugs Associated With Increased Mortality
  A new study shows nonadherence to antiepileptic medications is associated with a 3-fold increase in mortality risk among epilepsy patients, compared with those who are adherent. Medscape Medical News
Category:   Articles > Emergency Medicine


4. Pandemic Influenza
  The avian influenza pandemic threat requires clinicians to apply knowledge of disease epidemiology, treatment, and infection control. This activity reviews the data and guidelines to improve outcomes.
Medscape Infectious Diseases
Category:   Articles > Emergency Medicine


5. Survival Following HIV Infection of a Cohort Followed up From Seroconversion in the UK
  Survival with HIV continues to improve: In 2000-2006, the proportion of those recently infected and expected to survive 5, 10 and 15 years following seroconversion was 99%, 94% and 89%, respectively.
AIDS
Category:   Articles > Emergency Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS